Dimensional Fund Advisors LP Applied Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.76 - $2.64 $1,785 - $6,201
-2,349 Reduced 5.98%
36,961 $35,000
Q1 2022

May 13, 2022
SELL
$1.48 - $6.22 $49,750 - $209,085
-33,615 Reduced 46.1%
39,310 $83,000
Q4 2021

Feb 09, 2022
BUY
$8.77 - $18.29 $199,438 - $415,932
22,741 Added 45.32%
72,925 $653,000
Q3 2021

Nov 12, 2021
BUY
$13.54 - $22.06 $467,414 - $761,533
34,521 Added 220.4%
50,184 $832,000
Q2 2021

Aug 12, 2021
BUY
$14.05 - $25.04 $220,065 - $392,201
15,663 New
15,663 $325,000

Others Institutions Holding APLT

# of Institutions
143
Shares Held
111M
Call Options Held
1.68M
Put Options Held
1.91M
View Full List

About Applied Therapeutics Inc.

APLT Quotes by TradingView
  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $29.3M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email